1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. United States >
  5. California >
  6. Yatiri Bio Acquires NGeneBioAI

M&A Deal Summary

Yatiri Bio Acquires NGeneBioAI

On August 5, 2025, Yatiri Bio acquired life science company NGeneBioAI

Acquisition Highlights
  • This is Yatiri Bio’s 1st transaction in the Life Science sector.
  • This is Yatiri Bio’s 1st transaction in the United States.
  • This is Yatiri Bio’s 1st transaction in California.

M&A Deal Summary
Date 2025-08-05
Target NGeneBioAI
Sector Life Science
Buyer(s) Yatiri Bio
Deal Type Add-on Acquisition

Target

NGeneBioAI

San Diego, California, United States
NGeneBioAI specializes in plasma proteomics and AI-powered diagnostics. NGeneBioAI was formed in 2024 and is headquartered in San Diego, California.

Search 214,356 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Yatiri Bio

San Diego, California, United States
Category Company
Founded 2020
Sector Life Science
DESCRIPTION

Yatiri Bio is a precision therapeutics company that has developed an AI platform to identify responsive patient populations for poorly positioned clinical candidates. The Yatiri Bio platform enables prospective identification of sensitive patient subsets, significantly increasing the likelihood of clinical success. Yatiri Bio was formed in 2020 and is headquartered in San Diego, California.

DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
State: California M&A 1 of 1
Country: United States M&A 1 of 1
Year: 2025 M&A 1 of 1
Mergr

Solution for

Product

Company

Legal